nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CYCS—Parkinson's disease	0.411	0.538	CbGaD
Minocycline—CASP3—Parkinson's disease	0.216	0.282	CbGaD
Minocycline—IL1B—Parkinson's disease	0.137	0.18	CbGaD
Minocycline—CYCS—adrenal medulla—Parkinson's disease	0.0129	0.155	CbGeAlD
Minocycline—CASP3—adrenal medulla—Parkinson's disease	0.0111	0.133	CbGeAlD
Minocycline—IL1B—forelimb—Parkinson's disease	0.00406	0.0487	CbGeAlD
Minocycline—CASP3—nerve—Parkinson's disease	0.00278	0.0334	CbGeAlD
Minocycline—CASP3—tongue—Parkinson's disease	0.00272	0.0326	CbGeAlD
Minocycline—CYCS—hindbrain—Parkinson's disease	0.00243	0.0292	CbGeAlD
Minocycline—CASP3—hindbrain—Parkinson's disease	0.00208	0.025	CbGeAlD
Minocycline—IL1B—hindbrain—Parkinson's disease	0.00166	0.02	CbGeAlD
Minocycline—CYCS—embryo—Parkinson's disease	0.00152	0.0182	CbGeAlD
Minocycline—CASP1—forebrain—Parkinson's disease	0.0014	0.0168	CbGeAlD
Minocycline—CYCS—brainstem—Parkinson's disease	0.00139	0.0167	CbGeAlD
Minocycline—CYCS—forebrain—Parkinson's disease	0.00135	0.0161	CbGeAlD
Minocycline—CASP3—embryo—Parkinson's disease	0.0013	0.0156	CbGeAlD
Minocycline—CASP3—brainstem—Parkinson's disease	0.00119	0.0143	CbGeAlD
Minocycline—CASP1—cardiovascular system—Parkinson's disease	0.00118	0.0142	CbGeAlD
Minocycline—CASP3—forebrain—Parkinson's disease	0.00115	0.0138	CbGeAlD
Minocycline—CYCS—cardiovascular system—Parkinson's disease	0.00114	0.0136	CbGeAlD
Minocycline—IL1B—embryo—Parkinson's disease	0.00104	0.0125	CbGeAlD
Minocycline—CASP3—cardiovascular system—Parkinson's disease	0.000974	0.0117	CbGeAlD
Minocycline—IL1B—brainstem—Parkinson's disease	0.000954	0.0114	CbGeAlD
Minocycline—CASP1—midbrain—Parkinson's disease	0.000923	0.0111	CbGeAlD
Minocycline—IL1B—forebrain—Parkinson's disease	0.00092	0.011	CbGeAlD
Minocycline—CASP1—spinal cord—Parkinson's disease	0.0009	0.0108	CbGeAlD
Minocycline—CYCS—midbrain—Parkinson's disease	0.000888	0.0107	CbGeAlD
Minocycline—MMP9—embryo—Parkinson's disease	0.000867	0.0104	CbGeAlD
Minocycline—CYCS—spinal cord—Parkinson's disease	0.000867	0.0104	CbGeAlD
Minocycline—CASP3—medulla oblongata—Parkinson's disease	0.000832	0.00998	CbGeAlD
Minocycline—CASP1—head—Parkinson's disease	0.0008	0.0096	CbGeAlD
Minocycline—IL1B—cardiovascular system—Parkinson's disease	0.000778	0.00933	CbGeAlD
Minocycline—CYCS—head—Parkinson's disease	0.00077	0.00924	CbGeAlD
Minocycline—CASP1—nervous system—Parkinson's disease	0.000759	0.0091	CbGeAlD
Minocycline—CASP3—spinal cord—Parkinson's disease	0.000742	0.0089	CbGeAlD
Minocycline—CASP1—central nervous system—Parkinson's disease	0.00073	0.00876	CbGeAlD
Minocycline—CYCS—nervous system—Parkinson's disease	0.00073	0.00876	CbGeAlD
Minocycline—CASP1—cerebellum—Parkinson's disease	0.000714	0.00856	CbGeAlD
Minocycline—CYCS—central nervous system—Parkinson's disease	0.000703	0.00843	CbGeAlD
Minocycline—CYCS—cerebellum—Parkinson's disease	0.000687	0.00824	CbGeAlD
Minocycline—IL1B—medulla oblongata—Parkinson's disease	0.000665	0.00798	CbGeAlD
Minocycline—CASP3—head—Parkinson's disease	0.00066	0.00791	CbGeAlD
Minocycline—MMP9—cardiovascular system—Parkinson's disease	0.000649	0.00778	CbGeAlD
Minocycline—CASP3—nervous system—Parkinson's disease	0.000626	0.0075	CbGeAlD
Minocycline—IL1B—midbrain—Parkinson's disease	0.000608	0.00729	CbGeAlD
Minocycline—CASP3—central nervous system—Parkinson's disease	0.000602	0.00722	CbGeAlD
Minocycline—IL1B—spinal cord—Parkinson's disease	0.000593	0.00711	CbGeAlD
Minocycline—CASP3—cerebellum—Parkinson's disease	0.000589	0.00706	CbGeAlD
Minocycline—VEGFA—spinal cord—Parkinson's disease	0.000583	0.007	CbGeAlD
Minocycline—CASP1—brain—Parkinson's disease	0.00058	0.00695	CbGeAlD
Minocycline—CYCS—brain—Parkinson's disease	0.000558	0.00669	CbGeAlD
Minocycline—IL1B—head—Parkinson's disease	0.000527	0.00632	CbGeAlD
Minocycline—ALOX5—cardiovascular system—Parkinson's disease	0.000513	0.00615	CbGeAlD
Minocycline—IL1B—nervous system—Parkinson's disease	0.0005	0.00599	CbGeAlD
Minocycline—MMP9—spinal cord—Parkinson's disease	0.000494	0.00593	CbGeAlD
Minocycline—IL1B—central nervous system—Parkinson's disease	0.000481	0.00577	CbGeAlD
Minocycline—CASP3—brain—Parkinson's disease	0.000478	0.00573	CbGeAlD
Minocycline—VEGFA—cerebellum—Parkinson's disease	0.000463	0.00555	CbGeAlD
Minocycline—MMP9—head—Parkinson's disease	0.000439	0.00527	CbGeAlD
Minocycline—MMP9—nervous system—Parkinson's disease	0.000416	0.00499	CbGeAlD
Minocycline—MMP9—central nervous system—Parkinson's disease	0.000401	0.00481	CbGeAlD
Minocycline—IL1B—brain—Parkinson's disease	0.000382	0.00458	CbGeAlD
Minocycline—VEGFA—brain—Parkinson's disease	0.000376	0.00451	CbGeAlD
Minocycline—ALOX5—head—Parkinson's disease	0.000347	0.00416	CbGeAlD
Minocycline—ALOX5—nervous system—Parkinson's disease	0.000329	0.00395	CbGeAlD
Minocycline—MMP9—brain—Parkinson's disease	0.000318	0.00382	CbGeAlD
Minocycline—ALOX5—central nervous system—Parkinson's disease	0.000317	0.0038	CbGeAlD
Minocycline—ALOX5—cerebellum—Parkinson's disease	0.00031	0.00372	CbGeAlD
Minocycline—SLC22A7—brain—Parkinson's disease	0.000295	0.00353	CbGeAlD
Minocycline—SLC22A6—brain—Parkinson's disease	0.000284	0.00341	CbGeAlD
Minocycline—ALOX5—brain—Parkinson's disease	0.000252	0.00302	CbGeAlD
Minocycline—SLC22A8—head—Parkinson's disease	0.000235	0.00282	CbGeAlD
Minocycline—SLC22A8—nervous system—Parkinson's disease	0.000223	0.00267	CbGeAlD
Minocycline—SLC22A8—central nervous system—Parkinson's disease	0.000214	0.00257	CbGeAlD
Minocycline—SLC22A8—brain—Parkinson's disease	0.00017	0.00204	CbGeAlD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	3.61e-05	0.000236	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—ABL1—Parkinson's disease	3.55e-05	0.000232	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—MAPK8—Parkinson's disease	3.54e-05	0.000231	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VPS35—Parkinson's disease	3.53e-05	0.000231	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.53e-05	0.000231	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL6—Parkinson's disease	3.52e-05	0.00023	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL6—Parkinson's disease	3.49e-05	0.000228	CbGpPWpGaD
Minocycline—IL1B—Immune System—DCTN1—Parkinson's disease	3.48e-05	0.000227	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—SOD2—Parkinson's disease	3.42e-05	0.000224	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—Parkinson's disease	3.41e-05	0.000223	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HSPA8—Parkinson's disease	3.39e-05	0.000221	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—CP—Parkinson's disease	3.38e-05	0.000221	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—MAPK8—Parkinson's disease	3.37e-05	0.000221	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RIT2—Parkinson's disease	3.37e-05	0.00022	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—IL6—Parkinson's disease	3.37e-05	0.00022	CbGpPWpGaD
Minocycline—CASP1—Immune System—ADRBK1—Parkinson's disease	3.33e-05	0.000218	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	3.33e-05	0.000218	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PLA2G6—Parkinson's disease	3.31e-05	0.000217	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.31e-05	0.000217	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL6—Parkinson's disease	3.31e-05	0.000216	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—Parkinson's disease	3.3e-05	0.000216	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IL6—Parkinson's disease	3.29e-05	0.000215	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.28e-05	0.000215	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MAOB—Parkinson's disease	3.28e-05	0.000214	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GBA—Parkinson's disease	3.27e-05	0.000214	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—DBH—Parkinson's disease	3.27e-05	0.000214	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—FBP1—Parkinson's disease	3.27e-05	0.000214	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—GPX1—Parkinson's disease	3.27e-05	0.000214	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—Parkinson's disease	3.26e-05	0.000213	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL6—Parkinson's disease	3.22e-05	0.00021	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL6—Parkinson's disease	3.2e-05	0.000209	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GRK5—Parkinson's disease	3.19e-05	0.000209	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—DLG4—Parkinson's disease	3.18e-05	0.000208	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DRA—Parkinson's disease	3.16e-05	0.000207	CbGpPWpGaD
Minocycline—IL1B—Immune System—PLA2G6—Parkinson's disease	3.13e-05	0.000205	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—GRIN2B—Parkinson's disease	3.11e-05	0.000203	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—Parkinson's disease	3.09e-05	0.000202	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—ABL1—Parkinson's disease	3.08e-05	0.000201	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—CP—Parkinson's disease	3.06e-05	0.0002	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—VPS35—Parkinson's disease	3.06e-05	0.0002	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—FGB—Parkinson's disease	3.04e-05	0.000199	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	3.01e-05	0.000197	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL6—Parkinson's disease	3e-05	0.000196	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—Parkinson's disease	2.97e-05	0.000194	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HSPA8—Parkinson's disease	2.94e-05	0.000192	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DGKQ—Parkinson's disease	2.93e-05	0.000191	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GPR37—Parkinson's disease	2.93e-05	0.000191	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GRM4—Parkinson's disease	2.86e-05	0.000187	CbGpPWpGaD
Minocycline—IL1B—Immune System—PARK2—Parkinson's disease	2.86e-05	0.000187	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—Parkinson's disease	2.85e-05	0.000186	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF20—Parkinson's disease	2.83e-05	0.000185	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—Parkinson's disease	2.8e-05	0.000183	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	2.8e-05	0.000183	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.79e-05	0.000182	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	2.79e-05	0.000182	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—DLG4—Parkinson's disease	2.76e-05	0.00018	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	2.73e-05	0.000178	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	2.72e-05	0.000178	CbGpPWpGaD
Minocycline—CASP1—Immune System—ABL1—Parkinson's disease	2.72e-05	0.000178	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PENK—Parkinson's disease	2.72e-05	0.000178	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAG—Parkinson's disease	2.72e-05	0.000178	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—GRIN2B—Parkinson's disease	2.7e-05	0.000176	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PPP1R1B—Parkinson's disease	2.68e-05	0.000175	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.65e-05	0.000173	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	2.63e-05	0.000172	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—CP—Parkinson's disease	2.58e-05	0.000168	CbGpPWpGaD
Minocycline—CASP1—Immune System—HGF—Parkinson's disease	2.55e-05	0.000167	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—MAPK8—Parkinson's disease	2.55e-05	0.000167	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DGKQ—Parkinson's disease	2.54e-05	0.000166	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GPR37—Parkinson's disease	2.54e-05	0.000166	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ABL1—Parkinson's disease	2.53e-05	0.000166	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PDYN—Parkinson's disease	2.48e-05	0.000162	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP2D6—Parkinson's disease	2.44e-05	0.000159	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—Parkinson's disease	2.41e-05	0.000158	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.41e-05	0.000157	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—Parkinson's disease	2.4e-05	0.000157	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—DDC—Parkinson's disease	2.4e-05	0.000157	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.4e-05	0.000157	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CTGF—Parkinson's disease	2.39e-05	0.000156	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RIT2—Parkinson's disease	2.34e-05	0.000153	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	2.34e-05	0.000153	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GFAP—Parkinson's disease	2.34e-05	0.000153	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PPP1R1B—Parkinson's disease	2.32e-05	0.000152	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.31e-05	0.000151	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.31e-05	0.000151	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GRM5—Parkinson's disease	2.31e-05	0.000151	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—Parkinson's disease	2.3e-05	0.00015	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTA4—Parkinson's disease	2.27e-05	0.000148	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SOD1—Parkinson's disease	2.26e-05	0.000148	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.24e-05	0.000146	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP2E1—Parkinson's disease	2.23e-05	0.000146	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GRK5—Parkinson's disease	2.22e-05	0.000145	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NQO1—Parkinson's disease	2.21e-05	0.000144	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ABL1—Parkinson's disease	2.2e-05	0.000144	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.18e-05	0.000143	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TH—Parkinson's disease	2.17e-05	0.000142	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—Parkinson's disease	2.16e-05	0.000141	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ABL1—Parkinson's disease	2.16e-05	0.000141	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—Parkinson's disease	2.15e-05	0.000141	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—CP—Parkinson's disease	2.15e-05	0.000141	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IGF2—Parkinson's disease	2.15e-05	0.00014	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—MAPK8—Parkinson's disease	2.13e-05	0.00014	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.13e-05	0.000139	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MAPK8—Parkinson's disease	2.11e-05	0.000138	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.1e-05	0.000137	CbGpPWpGaD
Minocycline—IL1B—Immune System—ADRBK1—Parkinson's disease	2.08e-05	0.000136	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—CASP3—Parkinson's disease	2.06e-05	0.000134	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PLA2G6—Parkinson's disease	2.04e-05	0.000134	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—Parkinson's disease	2.04e-05	0.000133	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RIT2—Parkinson's disease	2.03e-05	0.000133	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HGF—Parkinson's disease	2.03e-05	0.000133	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF20—Parkinson's disease	2.02e-05	0.000132	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MAOB—Parkinson's disease	2.02e-05	0.000132	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.01e-05	0.000131	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—Parkinson's disease	1.99e-05	0.00013	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GRM4—Parkinson's disease	1.99e-05	0.00013	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—Parkinson's disease	1.98e-05	0.000129	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADORA2A—Parkinson's disease	1.96e-05	0.000128	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.93e-05	0.000126	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GRK5—Parkinson's disease	1.92e-05	0.000126	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.92e-05	0.000126	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PENK—Parkinson's disease	1.89e-05	0.000123	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAG—Parkinson's disease	1.89e-05	0.000123	CbGpPWpGaD
Minocycline—CYCS—Metabolism—COMT—Parkinson's disease	1.85e-05	0.000121	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTP1—Parkinson's disease	1.84e-05	0.00012	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.84e-05	0.00012	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MAOA—Parkinson's disease	1.83e-05	0.00012	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.82e-05	0.000119	CbGpPWpGaD
Minocycline—CYCS—Metabolism—HMOX1—Parkinson's disease	1.81e-05	0.000119	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—INSR—Parkinson's disease	1.81e-05	0.000118	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.76e-05	0.000115	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.75e-05	0.000114	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ABCB1—Parkinson's disease	1.74e-05	0.000114	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GRM4—Parkinson's disease	1.73e-05	0.000113	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDYN—Parkinson's disease	1.72e-05	0.000113	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGB—Parkinson's disease	1.71e-05	0.000112	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR1A—Parkinson's disease	1.7e-05	0.000111	CbGpPWpGaD
Minocycline—IL1B—Immune System—ABL1—Parkinson's disease	1.7e-05	0.000111	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTM1—Parkinson's disease	1.69e-05	0.00011	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.68e-05	0.00011	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TAC1—Parkinson's disease	1.68e-05	0.00011	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—INS—Parkinson's disease	1.67e-05	0.000109	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD1—Parkinson's disease	1.65e-05	0.000108	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MAPK8—Parkinson's disease	1.64e-05	0.000107	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PENK—Parkinson's disease	1.64e-05	0.000107	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAG—Parkinson's disease	1.64e-05	0.000107	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—Parkinson's disease	1.63e-05	0.000107	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GFAP—Parkinson's disease	1.62e-05	0.000106	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GPX1—Parkinson's disease	1.62e-05	0.000106	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GRM5—Parkinson's disease	1.6e-05	0.000105	CbGpPWpGaD
Minocycline—IL1B—Immune System—HGF—Parkinson's disease	1.6e-05	0.000104	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—Parkinson's disease	1.6e-05	0.000104	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD3—Parkinson's disease	1.59e-05	0.000104	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.53e-05	0.0001	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.53e-05	0.0001	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP2D6—Parkinson's disease	1.5e-05	9.82e-05	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—Parkinson's disease	1.5e-05	9.81e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDYN—Parkinson's disease	1.5e-05	9.78e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTHFR—Parkinson's disease	1.49e-05	9.77e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRBK1—Parkinson's disease	1.49e-05	9.73e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CTGF—Parkinson's disease	1.47e-05	9.64e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.47e-05	9.62e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.47e-05	9.61e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—INS—Parkinson's disease	1.45e-05	9.5e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD2—Parkinson's disease	1.44e-05	9.42e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR7—Parkinson's disease	1.44e-05	9.42e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GFAP—Parkinson's disease	1.41e-05	9.2e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF20—Parkinson's disease	1.41e-05	9.19e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GRM5—Parkinson's disease	1.39e-05	9.1e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—APOE—Parkinson's disease	1.39e-05	9.09e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP2E1—Parkinson's disease	1.37e-05	8.98e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADORA2A—Parkinson's disease	1.36e-05	8.91e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NQO1—Parkinson's disease	1.36e-05	8.88e-05	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—Parkinson's disease	1.35e-05	8.81e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—Parkinson's disease	1.34e-05	8.76e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TH—Parkinson's disease	1.34e-05	8.76e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYCS—Parkinson's disease	1.29e-05	8.41e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.28e-05	8.36e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—INSR—Parkinson's disease	1.26e-05	8.22e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—MAPK8—Parkinson's disease	1.23e-05	8.03e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.23e-05	8.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF20—Parkinson's disease	1.22e-05	7.98e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF2—Parkinson's disease	1.21e-05	7.89e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGB—Parkinson's disease	1.19e-05	7.77e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—INS—Parkinson's disease	1.19e-05	7.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADORA2A—Parkinson's disease	1.18e-05	7.73e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR1A—Parkinson's disease	1.18e-05	7.73e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1R—Parkinson's disease	1.17e-05	7.63e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TAC1—Parkinson's disease	1.16e-05	7.61e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EDN1—Parkinson's disease	1.15e-05	7.54e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD1—Parkinson's disease	1.14e-05	7.47e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—COMT—Parkinson's disease	1.14e-05	7.44e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTP1—Parkinson's disease	1.13e-05	7.41e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MAOA—Parkinson's disease	1.13e-05	7.39e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HMOX1—Parkinson's disease	1.12e-05	7.31e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD3—Parkinson's disease	1.11e-05	7.23e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—INSR—Parkinson's disease	1.09e-05	7.14e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ABCB1—Parkinson's disease	1.07e-05	7.01e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NGF—Parkinson's disease	1.06e-05	6.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—Parkinson's disease	1.05e-05	6.85e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTM1—Parkinson's disease	1.04e-05	6.81e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRBK1—Parkinson's disease	1.03e-05	6.75e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGB—Parkinson's disease	1.03e-05	6.75e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR1A—Parkinson's disease	1.03e-05	6.71e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—Parkinson's disease	1.02e-05	6.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TAC1—Parkinson's disease	1.01e-05	6.61e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2A—Parkinson's disease	1.01e-05	6.6e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD2—Parkinson's disease	1e-05	6.54e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR7—Parkinson's disease	1e-05	6.54e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GPX1—Parkinson's disease	9.97e-06	6.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD1—Parkinson's disease	9.91e-06	6.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD3—Parkinson's disease	9.6e-06	6.28e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOE—Parkinson's disease	9.38e-06	6.13e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—Parkinson's disease	9.2e-06	6.02e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—Parkinson's disease	9.06e-06	5.92e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRBK1—Parkinson's disease	8.97e-06	5.86e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—Parkinson's disease	8.89e-06	5.81e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR7—Parkinson's disease	8.68e-06	5.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD2—Parkinson's disease	8.68e-06	5.68e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOE—Parkinson's disease	8.57e-06	5.6e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF2—Parkinson's disease	8.38e-06	5.48e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1R—Parkinson's disease	8.11e-06	5.3e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—INS—Parkinson's disease	8.02e-06	5.24e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EDN1—Parkinson's disease	8.01e-06	5.24e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—Parkinson's disease	7.86e-06	5.14e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—Parkinson's disease	7.85e-06	5.13e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK8—Parkinson's disease	7.68e-06	5.02e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NGF—Parkinson's disease	7.36e-06	4.81e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—INS—Parkinson's disease	7.32e-06	4.79e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—Parkinson's disease	7.31e-06	4.78e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF2—Parkinson's disease	7.28e-06	4.76e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1R—Parkinson's disease	7.04e-06	4.6e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2A—Parkinson's disease	7.01e-06	4.58e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EDN1—Parkinson's disease	6.95e-06	4.55e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOE—Parkinson's disease	6.51e-06	4.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NGF—Parkinson's disease	6.39e-06	4.18e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—Parkinson's disease	6.35e-06	4.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2A—Parkinson's disease	6.08e-06	3.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOE—Parkinson's disease	5.65e-06	3.7e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—INS—Parkinson's disease	5.56e-06	3.64e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK8—Parkinson's disease	5.48e-06	3.59e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—Parkinson's disease	4.9e-06	3.21e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—INS—Parkinson's disease	4.83e-06	3.16e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CASP3—Parkinson's disease	4.14e-06	2.71e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK8—Parkinson's disease	3.81e-06	2.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CASP3—Parkinson's disease	3.6e-06	2.35e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—Parkinson's disease	3.5e-06	2.29e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK8—Parkinson's disease	3.31e-06	2.16e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—Parkinson's disease	2.43e-06	1.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—Parkinson's disease	2.11e-06	1.38e-05	CbGpPWpGaD
